Skip to main content
There are many types of kidney disease. Often, kidney disease is associated with other medical conditions such as diabetes. Diabetic kidney disease is a serious kidney-related complication of type 1 diabetes and type 2 diabetes. Most diseases of the kidney attack the filtering units in the kidney, damaging their ability to remove wastes and excess fluids. There is no cure, but it may be possible to prevent CKD or slow down worsening of kidney function. At least half of people with diabetes may show signs of early kidney damage. If left untreated, this could lead to more kidney damage or kidney failure.

This webinar will share the experiences of patients with diabetes and kidney disease, and provide important information about diabetes and kidney disease.

This webinar will be offered in English and French with simultaneous translation available in your language of choice.  

Dec 6, 2021 11:30 AM


Watch Webinar



Charles Cook


I am a 2-time transplant recipient.  I received my heart in the spring of 2016.  I received my kidney 1.5 years later in the fall of 2017.  I developed prednisone induced diabetes in 2019 as a side effect of treatment for lung disease.  My diabetes is currently in remission, and I can control the condition through diet and exercise.  I am a long time, active and enthusiastic volunteer with both the Transplant Ambassador Program (TAP) and the Kidney Foundation. 

Christopher R.J. Kennedy, Ph.D.   


Christopher Kennedy is a Senior Scientist within the Chronic Disease Program and Kidney Research Centre at the Ottawa Hospital Research Institute and a Full Professor in the Faculty of Medicine / Department of Medicine at the University of Ottawa.  Employing state-of-the-art models, his research seeks to identify how the kidney’s filtration system and vasculature are damaged in diabetes and high blood pressure – the two leading causes of kidney disease in Canada, with the goal of translating his work into novel therapies that would slow down or prevent kidney disease progression. 

Dr. Justin Chun, Ph.D.   


Dr. Chun is a currently a KRESCENT New Investigator and the Assistant Director for the Precision Medicine in Nephrology Program at the University of Calgary. His current research interests include understanding how lipids and lipid droplet-associated proteins contribute to glomerular and diabetic kidney disease. He is generating stem cells from patients with diabetic kidney disease and glomerular disease for disease modelling and drug testing. His molecular medicine, patient-oriented research program focuses on identifying biomarkers and therapies to improve patient care.  

Complete bio information is available upon request. Contact


The Kidney Foundation, would like to thank our sponsors for making the 2021 Kidney Foundation Webinar Series possible.